Abstract
Muscle atrophy may occur under different circumstances throughout a person’s life. These conditions include periods of immobilization of a limb or of the whole body and aging accompanied by the onset of sarcopenia. Muscle mass is reduced as a result of decreased protein synthesis or increased protein degradation. Most studies aim to prevent the degradation of muscle proteins, but the way in which protein synthesis can be stimulated is often neglected. This study will provide an up-to-date review regarding nutritional considerations and resistance exercise countermeasures in the prevention of muscle mass loss and recovery of muscle mass in muscle atrophy secondary to immobilization or in sarcopenic obesity. We do not address muscle atrophy in disease states associated with inflammation (rheumatoid arthritis, COPD, cancer cachexia, AIDS, burns, sepsis, and uremia) which are governed by particular mechanisms of muscle loss.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Grosset JF, Onambele-Pearson G (2008) Effect of foot and ankle immobilization on leg and thigh muscles’ volume and morphology: a case study using magnetic resonance imaging. Anat Rec 291(12):1673–1683. https://doi.org/10.1002/ar.20759
Haruna Y, Suzuki Y, Kawakubo K, Yanagibori R, Gunji A (1994) Decremental reset in basal metabolism during 20-days bed rest. Acta Physiol Scand Suppl 616:43–49
Dirks ML, Wall BT, van de Valk B, Holloway TM, Holloway GP, Chabowski A, Goossens GH, van Loon LJ (2016) One week of bed rest leads to substantial muscle atrophy and induces whole-body insulin resistance in the absence of skeletal muscle lipid accumulation. Diabetes 65(10):2862–2875. https://doi.org/10.2337/db15-1661
Brooks N, Cloutier GJ, Cadena SM, Layne JE, Nelsen CA, Freed AM, Roubenoff R, Castaneda-Sceppa C (2008) Resistance training and timed essential amino acids protect against the loss of muscle mass and strength during 28 days of bed rest and energy deficit. J Appl Physiol 105(1):241–248. https://doi.org/10.1152/japplphysiol.01346.2007
von Haehling S, Morley JE, Anker SD (2012) From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle 3(4):213–217. https://doi.org/10.1007/s13539-012-0089-z
Keller K (2018) Sarcopenia. Wien Med Wochenschr. https://doi.org/10.1007/s10354-018-0618-2
Wall BT, Dirks ML, Snijders T, van Dijk JW, Fritsch M, Verdijk LB, van Loon LJ (2016) Short-term muscle disuse lowers myofibrillar protein synthesis rates and induces anabolic resistance to protein ingestion. Am J Phys Endocrinol Metab 310(2):E137–E147. https://doi.org/10.1152/ajpendo.00227.2015
Dirks ML, Wall BT, van Loon LJC (2017) Interventional strategies to combat muscle disuse atrophy in humans: focus on neuromuscular electrical stimulation and dietary protein. Journal of applied physiology:jap009852016. https://doi.org/10.1152/japplphysiol.00985.2016
Wall BT, Dirks ML, Snijders T, Senden JM, Dolmans J, van Loon LJ (2014) Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiol 210(3):600–611. https://doi.org/10.1111/apha.12190
Bodine SC (2013) Disuse-induced muscle wasting. Int J Biochem Cell Biol 45(10):2200–2208. https://doi.org/10.1016/j.biocel.2013.06.011
Rudrappa SS, Wilkinson DJ, Greenhaff PL, Smith K, Idris I, Atherton PJ (2016) Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance-a qualitative review. Front Physiol 7:361. https://doi.org/10.3389/fphys.2016.00361
Topp R, Ditmyer M, King K, Doherty K, Hornyak J 3rd (2002) The effect of bed rest and potential of prehabilitation on patients in the intensive care unit. AACN Clin Issues 13(2):263–276
Psatha M, Wu Z, Gammie FM, Ratkevicius A, Wackerhage H, Lee JH, Redpath TW, Gilbert FJ, Ashcroft GP, Meakin JR, Aspden RM (2012) A longitudinal MRI study of muscle atrophy during lower leg immobilization following ankle fracture. J Magn Resonan Imaging 35(3):686–695. https://doi.org/10.1002/jmri.22864
Biolo G, Agostini F, Simunic B, Sturma M, Torelli L, Preiser JC, Deby-Dupont G, Magni P, Strollo F, di Prampero P, Guarnieri G, Mekjavic IB, Pisot R, Narici MV (2008) Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 88(4):950–958
Pasiakos SM, Vislocky LM, Carbone JW, Altieri N, Konopelski K, Freake HC, Anderson JM, Ferrando AA, Wolfe RR, Rodriguez NR (2010) Acute energy deprivation affects skeletal muscle protein synthesis and associated intracellular signaling proteins in physically active adults. J Nutr 140(4):745–751. https://doi.org/10.3945/jn.109.118372
Trappe TA, Burd NA, Louis ES, Lee GA, Trappe SW (2007) Influence of concurrent exercise or nutrition countermeasures on thigh and calf muscle size and function during 60 days of bed rest in women. Acta Physiol 191(2):147–159. https://doi.org/10.1111/j.1748-1716.2007.01728.x
Wall BT, van Loon LJ (2013) Nutritional strategies to attenuate muscle disuse atrophy. Nutr Rev 71(4):195–208. https://doi.org/10.1111/nure.12019
Bohe J, Low A, Wolfe RR, Rennie MJ (2003) Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol 552(Pt 1):315–324. https://doi.org/10.1113/jphysiol.2003.050674
Dirks ML, Wall BT, Nilwik R, Weerts DH, Verdijk LB, van Loon LJ (2014) Skeletal muscle disuse atrophy is not attenuated by dietary protein supplementation in healthy older men. J Nutr 144(8):1196–1203. https://doi.org/10.3945/jn.114.194217
Dardevet D, Remond D, Peyron MA, Papet I, Savary-Auzeloux I, Mosoni L (2012) Muscle wasting and resistance of muscle anabolism: the “anabolic threshold concept” for adapted nutritional strategies during sarcopenia. TheScientificWorldJOURNAL 2012:269531. https://doi.org/10.1100/2012/269531
Stuart CA, Shangraw RE, Peters EJ, Wolfe RR (1990) Effect of dietary protein on bed-rest-related changes in whole-body-protein synthesis. Am J Clin Nutr 52(3):509–514
Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR (2003) Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr 78(2):250–258
Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ (2010) Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids 38(5):1533–1539. https://doi.org/10.1007/s00726-009-0377-x
Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E, Rasmussen BB (2010) An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am J Phys Endocrinol Metab 298(5):E1011–E1018. https://doi.org/10.1152/ajpendo.00690.2009
Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, Kimball SR, Jefferson LS (2002) Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am J Phys Endocrinol Metab 282(5):E1092–E1101. https://doi.org/10.1152/ajpendo.00208.2001
Drummond MJ, Reidy PT, Baird LM, Dalley BK, Howard MT (2017) Leucine differentially regulates gene-specific translation in mouse skeletal muscle. J Nutr 147(9):1616–1623. https://doi.org/10.3945/jn.117.251181
Paddon-Jones D, Sheffield-Moore M, Urban RJ, Sanford AP, Aarsland A, Wolfe RR, Ferrando AA (2004) Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 89(9):4351–4358. https://doi.org/10.1210/jc.2003-032159
Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2005) Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 82(5):1065–1073
Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2006) A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Phys Endocrinol Metab 291(2):E381–E387. https://doi.org/10.1152/ajpendo.00488.2005
Brooks NE, Cadena SM, Vannier E, Cloutier G, Carambula S, Myburgh KH, Roubenoff R, Castaneda-Sceppa C (2010) Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during bed rest and active recovery. Muscle Nerve 42(6):927–935. https://doi.org/10.1002/mus.21780
Dreyer HC, Drummond MJ, Pennings B, Fujita S, Glynn EL, Chinkes DL, Dhanani S, Volpi E, Rasmussen BB (2008) Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Phys Endocrinol Metab 294(2):E392–E400. https://doi.org/10.1152/ajpendo.00582.2007
Louard RJ, Barrett EJ, Gelfand RA (1990) Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci 79(5):457–466
Wolfe RR (2017) Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr 14:30. https://doi.org/10.1186/s12970-017-0184-9
Stein TP, Blanc S (2011) Does protein supplementation prevent muscle disuse atrophy and loss of strength? Crit Rev Food Sci Nutr 51(9):828–834. https://doi.org/10.1080/10408398.2010.482679
Sundstrom Rehal M, Liebau F, Tjader I, Norberg A, Rooyackers O, Wernerman J (2017) A supplemental intravenous amino acid infusion sustains a positive protein balance for 24 hours in critically ill patients. Crit Care 21(1):298. https://doi.org/10.1186/s13054-017-1892-x
Martin V, Ratel S, Siracusa J, Le Ruyet P, Savary-Auzeloux I, Combaret L, Guillet C, Dardevet D (2013) Whey proteins are more efficient than casein in the recovery of muscle functional properties following a casting induced muscle atrophy. PLoS One 8(9):e75408. https://doi.org/10.1371/journal.pone.0075408
Kimball SR, Jefferson LS (2006) Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr 136(1 Suppl):227S–231S
Maki T, Yamamoto D, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y (2012) Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats. Nutr Res 32(9):676–683. https://doi.org/10.1016/j.nutres.2012.07.005
De Luca A, Pierno S, Camerino DC (2015) Taurine: the appeal of a safe amino acid for skeletal muscle disorders. J Transl Med 13:243. https://doi.org/10.1186/s12967-015-0610-1
Ghandforoush-Sattari M, Mashayekhi S, Krishna CV, Thompson JP, Routledge PA (2010) Pharmacokinetics of oral taurine in healthy volunteers. J Amino Acids 2010:346237. https://doi.org/10.4061/2010/346237
Khalil RM, Abdo WS, Saad A, Khedr EG (2017) Muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy. Mol Cell Biochem. https://doi.org/10.1007/s11010-017-3240-5
Dutt V, Saini V, Gupta P, Kaur N, Bala M, Gujar R, Grewal A, Gupta S, Dua A, Mittal A (2018) S-allyl cysteine inhibits TNFalpha-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules. Biochim Biophys Acta 1862(4):895–906. https://doi.org/10.1016/j.bbagen.2017.12.015
Breuille D, Bechereau F, Buffiere C, Denis P, Pouyet C, Obled C (2006) Beneficial effect of amino acid supplementation, especially cysteine, on body nitrogen economy in septic rats. Clin Nutr 25(4):634–642. https://doi.org/10.1016/j.clnu.2005.11.009
Derave W, Eijnde BO, Hespel P (2003) Creatine supplementation in health and disease: what is the evidence for long-term efficacy? Mol Cell Biochem 244(1-2):49–55
Backx EMP, Hangelbroek R, Snijders T, Verscheijden ML, Verdijk LB, de Groot L, van Loon LJC (2017) Creatine loading does not preserve muscle mass or strength during leg immobilization in healthy, young males: a randomized controlled trial. Sports Med 47(8):1661–1671. https://doi.org/10.1007/s40279-016-0670-2
Chilibeck PD, Kaviani M, Candow DG, Zello GA (2017) Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med 8:213–226. https://doi.org/10.2147/OAJSM.S123529
Hespel P, Op't Eijnde B, Van Leemputte M, Urso B, Greenhaff PL, Labarque V, Dymarkowski S, Van Hecke P, Richter EA (2001) Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol 536(Pt 2):625–633
Powers SK, Kavazis AN, McClung JM (2007) Oxidative stress and disuse muscle atrophy. J Appl Physiol 102(6):2389–2397. https://doi.org/10.1152/japplphysiol.01202.2006
Pellegrino MA, Desaphy JF, Brocca L, Pierno S, Camerino DC, Bottinelli R (2011) Redox homeostasis, oxidative stress and disuse muscle atrophy. J Physiol 589(Pt 9):2147–2160. https://doi.org/10.1113/jphysiol.2010.203232
Cornelli U (2009) Antioxidant use in nutraceuticals. Clin Dermatol 27(2):175–194. https://doi.org/10.1016/j.clindermatol.2008.01.010
Kondo H, Miura M, Itokawa Y (1991) Oxidative stress in skeletal muscle atrophied by immobilization. Acta Physiol Scand 142(4):527–528. https://doi.org/10.1111/j.1748-1716.1991.tb09191.x
Appell HJ, Duarte JA, Soares JM (1997) Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Int J Sports Med 18(3):157–160
Servais S, Letexier D, Favier R, Duchamp C, Desplanches D (2007) Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis? Free Radic Biol Med 42(5):627–635. https://doi.org/10.1016/j.freeradbiomed.2006.12.001
Koesterer TJ, Dodd SL, Powers S (2002) Increased antioxidant capacity does not attenuate muscle atrophy caused by unweighting. J Appl Physiol 93(6):1959–1965. https://doi.org/10.1152/japplphysiol.00511.2002
Kanazashi M, Tanaka M, Murakami S, Kondo H, Nagatomo F, Ishihara A, Roy RR, Fujino H (2014) Amelioration of capillary regression and atrophy of the soleus muscle in hindlimb-unloaded rats by astaxanthin supplementation and intermittent loading. Exp Physiol 99(8):1065–1077. https://doi.org/10.1113/expphysiol.2014.079988
Ogawa M, Kariya Y, Kitakaze T, Yamaji R, Harada N, Sakamoto T, Hosotani K, Nakano Y, Inui H (2013) The preventive effect of beta-carotene on denervation-induced soleus muscle atrophy in mice. Br J Nutr 109(8):1349–1358. https://doi.org/10.1017/S0007114512003297
Bosutti A, Degens H (2015) The impact of resveratrol and hydrogen peroxide on muscle cell plasticity shows a dose-dependent interaction. Sci Rep 5:8093. https://doi.org/10.1038/srep08093
Bennett BT, Mohamed JS, Alway SE (2013) Effects of resveratrol on the recovery of muscle mass following disuse in the plantaris muscle of aged rats. PLoS One 8(12):e83518. https://doi.org/10.1371/journal.pone.0083518
Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP, Sebedio JL, Pujos-Guillot E, Falempin M, Simon C, Coxam V, Andrianjafiniony T, Gauquelin-Koch G, Picquet F, Blanc S (2011) Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB journal : official publication of the FASEB J 25(10):3646–3660. https://doi.org/10.1096/fj.10-177295
Cabrera C, Artacho R, Gimenez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25(2):79–99
Suzuki T, Pervin M, Goto S, Isemura M, Nakamura Y (2016) Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity. Molecules 21(10). https://doi.org/10.3390/molecules21101305
Meador BM, Mirza KA, Tian M, Skelding MB, Reaves LA, Edens NK, Tisdale MJ, Pereira SL (2015) The green tea polyphenol epigallocatechin-3-gallate (EGCg) attenuates skeletal muscle atrophy in a rat model of sarcopenia. J Frailty Aging 4(4):209–215. https://doi.org/10.14283/jfa.2015.58
Ota N, Soga S, Haramizu S, Yokoi Y, Hase T, Murase T (2011) Tea catechins prevent contractile dysfunction in unloaded murine soleus muscle: a pilot study. Nutrition 27(9):955–959. https://doi.org/10.1016/j.nut.2010.10.008
Alway SE, Bennett BT, Wilson JC, Sperringer J, Mohamed JS, Edens NK, Pereira SL (2015) Green tea extract attenuates muscle loss and improves muscle function during disuse, but fails to improve muscle recovery following unloading in aged rats. J Appl Physiol 118(3):319–330. https://doi.org/10.1152/japplphysiol.00674.2014
Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, Song G, Kim HJ, Choi YJ, Kim KM (2012) Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 67(10):1107–1113. https://doi.org/10.1093/gerona/gls071
Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M (2012) Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 31(5):583–601. https://doi.org/10.1016/j.clnu.2012.06.010
Johnson Stoklossa CA, Sharma AM, Forhan M, Siervo M, Padwal RS, Prado CM (2017) Prevalence of sarcopenic obesity in adults with class II/III obesity using different diagnostic criteria. J Nutr Metab 2017:7307618. https://doi.org/10.1155/2017/7307618
Marcell TJ (2003) Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 58(10):M911–M916
Thomas DR (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26(4):389–399. https://doi.org/10.1016/j.clnu.2007.03.008
Rosenberg IH (2011) Sarcopenia: origins and clinical relevance. Clin Geriatr Med 27(3):337–339. https://doi.org/10.1016/j.cger.2011.03.003
Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311(8):806–814. https://doi.org/10.1001/jama.2014.732
Doherty TJ, Vandervoort AA, Brown WF (1993) Effects of ageing on the motor unit: a brief review. Can J Appl Physiol = Revue canadienne de physiologie appliquee 18(4):331–358
Campbell MJ, McComas AJ, Petito F (1973) Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry 36(2):174–182
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763
Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896
Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB, Health ABCSI (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51(11):1602–1609
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95(5):1851–1860. https://doi.org/10.1152/japplphysiol.00246.2003
Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064
Hughes VA, Frontera WR, Wood M, Evans WJ, Dallal GE, Roubenoff R, Fiatarone Singh MA (2001) Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci 56(5):B209–B217
Larsson L, Li X, Frontera WR (1997) Effects of aging on shortening velocity and myosin isoform composition in single human skeletal muscle cells. Am J Phys 272(2 Pt 1):C638–C649. https://doi.org/10.1152/ajpcell.1997.272.2.C638
Delbono O (2003) Neural control of aging skeletal muscle. Aging Cell 2(1):21–29
Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, Stamm E, Newman AB (2001) Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 90(6):2157–2165. https://doi.org/10.1152/jappl.2001.90.6.2157
Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB (2006) Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61(1):72–77
Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L (2008) Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11(6):693–700. https://doi.org/10.1097/MCO.0b013e328312c37d
Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB (2005) Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 60(3):324–333
Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, Ferrucci L (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102(3):919–925. https://doi.org/10.1152/japplphysiol.00627.2006
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older P (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558. https://doi.org/10.1093/gerona/glu010
Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Vassileva MT, Studenski SA, Alley DE (2014) Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 69(5):567–575. https://doi.org/10.1093/gerona/glu023
Kim KM, Jang HC, Lim S (2016) Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Inter Med 31(4):643–650. https://doi.org/10.3904/kjim.2016.015
Choi KM (2016) Sarcopenia and sarcopenic obesity. Korean J Inter Med 31(6):1054–1060. https://doi.org/10.3904/kjim.2016.193
Villareal DT, Banks M, Siener C, Sinacore DR, Klein S (2004) Physical frailty and body composition in obese elderly men and women. Obes Res 12(6):913–920. https://doi.org/10.1038/oby.2004.111
Zizza CA, Herring A, Stevens J, Popkin BM (2002) Obesity affects nursing-care facility admission among whites but not blacks. Obes Res 10(8):816–823. https://doi.org/10.1038/oby.2002.110
Rantanen T, Penninx BW, Masaki K, Lintunen T, Foley D, Guralnik JM (2000) Depressed mood and body mass index as predictors of muscle strength decline in old men. J Am Geriatr Soc 48(6):613–617
Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12(12):1995–2004. https://doi.org/10.1038/oby.2004.250
Stenholm S, Alley D, Bandinelli S, Griswold ME, Koskinen S, Rantanen T, Guralnik JM, Ferrucci L (2009) The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int J Obes 33(6):635–644. https://doi.org/10.1038/ijo.2009.62
Stenholm S, Rantanen T, Heliovaara M, Koskinen S (2008) The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc 56(3):462–469. https://doi.org/10.1111/j.1532-5415.2007.01567.x
Droyvold WB, Nilsen TI, Kruger O, Holmen TL, Krokstad S, Midthjell K, Holmen J (2006) Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway. Int J Obes 30(6):935–939. https://doi.org/10.1038/sj.ijo.0803178
Ding J, Kritchevsky SB, Newman AB, Taaffe DR, Nicklas BJ, Visser M, Lee JS, Nevitt M, Tylavsky FA, Rubin SM, Pahor M, Harris TB, Health ABCS (2007) Effects of birth cohort and age on body composition in a sample of community-based elderly. Am J Clin Nutr 85(2):405–410
Bassey EJ (1998) Longitudinal changes in selected physical capabilities: muscle strength, flexibility and body size. Age Ageing 27(Suppl 3):12–16
Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R (2000) Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 88(4):1321–1326. https://doi.org/10.1152/jappl.2000.88.4.1321
Horber FF, Gruber B, Thomi F, Jensen EX, Jaeger P (1997) Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition 13(6):524–534
Beaufrere B, Morio B (2000) Fat and protein redistribution with aging: metabolic considerations. Eur J Clin Nutr 54(Suppl 3):S48–S53
Roubenoff R (2003) Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci 58(11):1012–1017
Duvigneaud N, Matton L, Wijndaele K, Deriemaeker P, Lefevre J, Philippaerts R, Thomis M, Delecluse C, Duquet W (2008) Relationship of obesity with physical activity, aerobic fitness and muscle strength in Flemish adults. J Sports Med Phys Fitness 48(2):201–210
Vincent HK, Raiser SN, Vincent KR (2012) The aging musculoskeletal system and obesity-related considerations with exercise. Ageing Res Rev 11(3):361–373. https://doi.org/10.1016/j.arr.2012.03.002
Goisser S, Kemmler W, Porzel S, Volkert D, Sieber CC, Bollheimer LC, Freiberger E (2015) Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons – -a narrative review. Clin Interv Aging 10:1267–1282. https://doi.org/10.2147/CIA.S82454
Denison HJ, Cooper C, Sayer AA, Robinson SM (2015) Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging 10:859–869. https://doi.org/10.2147/CIA.S55842
Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911–919.; ; quiz 920. https://doi.org/10.1016/j.jaci.2005.02.023
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56(4):1010–1013. https://doi.org/10.2337/db06-1656
Hung J, McQuillan BM, Thompson PL, Beilby JP (2008) Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes 32(5):772–779. https://doi.org/10.1038/sj.ijo.0803793
Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M (2005) Sarcopenia, obesity, and inflammation – results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 82(2):428–434
Barbieri M, Ferrucci L, Corsi AM, Macchi C, Lauretani F, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Paolisso G (2003) Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 16(7):537–543
Roth SM, Metter EJ, Ling S, Ferrucci L (2006) Inflammatory factors in age-related muscle wasting. Curr Opin Rheumatol 18(6):625–630. https://doi.org/10.1097/01.bor.0000245722.10136.6d
Sakuma K, Yamaguchi A (2013) Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol 2013:204164. https://doi.org/10.1155/2013/204164
Yang CW, Li CI, Li TC, Liu CS, Lin CH, Lin WY, Lin CC (2015) Association of sarcopenic obesity with higher serum high-sensitivity C-reactive protein levels in Chinese older males – a community-based study (Taichung Community Health Study-Elderly, TCHS-E). PLoS One 10(7):e0132908. https://doi.org/10.1371/journal.pone.0132908
Dyck DJ, Heigenhauser GJ, Bruce CR (2006) The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 186(1):5–16. https://doi.org/10.1111/j.1748-1716.2005.01502.x
Stenholm S, Metter EJ, Roth GS, Ingram DK, Mattison JA, Taub DD, Ferrucci L (2011) Relationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore Longitudinal Study of Aging. Aging Clin Exp Res 23(2):153–158
Arner P, Ryden M (2015) Fatty acids, obesity and insulin resistance. Obes Facts 8(2):147–155. https://doi.org/10.1159/000381224
Nomura T, Ikeda Y, Nakao S, Ito K, Ishida K, Suehiro T, Hashimoto K (2007) Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocr J 54(5):791–796
Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, Bandinelli S, Barbieri M, Valenti G, Paolisso G (2005) Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 60(10):1278–1282
Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Cho YW, Newman AB, Health A, Body Composition S (2007) Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 30(6):1507–1512. https://doi.org/10.2337/dc06-2537
Roberts CK, Hevener AL, Barnard RJ (2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol 3(1):1–58. https://doi.org/10.1002/cphy.c110062
Santos GM, Montrezol FT, Pauli LS, Sartori-Cintra AR, Colantonio E, Gomes RJ, Marinho R, Moura LP, Pauli JR (2014) Undulatory physical resistance training program increases maximal strength in elderly type 2 diabetics. Einstein 12(4):425–432. https://doi.org/10.1590/S1679-45082014AO3162
Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87(2):589–598. https://doi.org/10.1210/jcem.87.2.8201
Morley JE, Perry HM 3rd (2003) Androgens and women at the menopause and beyond. J Gerontol A Biol Sci Med Sci 58(5):M409–M416
Florini JR, Ewton DZ, Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17(5):481–517. https://doi.org/10.1210/edrv-17-5-481
Moran A, Jacobs DR Jr, Steinberger J, Cohen P, Hong CP, Prineas R, Sinaiko AR (2002) Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. J Clin Endocrinol Metab 87(10):4817–4820. https://doi.org/10.1210/jc.2002-020517
Hermann M, Berger P (2001) Hormonal changes in aging men: a therapeutic indication? Exp Gerontol 36(7):1075–1082
Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9(4):213–228. https://doi.org/10.1007/s10522-008-9131-0
Nass R, Johannsson G, Christiansen JS, Kopchick JJ, Thorner MO (2009) The aging population – is there a role for endocrine interventions? Growth Hormo IGF Res 19(2):89–100. https://doi.org/10.1016/j.ghir.2008.09.002
Sakuma K, Yamaguchi A (2010) Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci 3(2):90–101
Allan CA, Strauss BJ, McLachlan RI (2007) Body composition, metabolic syndrome and testosterone in ageing men. Int J Impot Res 19(5):448–457. https://doi.org/10.1038/sj.ijir.3901552
Chu LW, Tam S, Kung AW, Lo S, Fan S, Wong RL, Morley JE, Lam KS (2008) Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men. J Am Geriatr Soc 56(7):1286–1291. https://doi.org/10.1111/j.1532-5415.2008.01746.x
Umpleby AM, Russell-Jones DL (1996) The hormonal control of protein metabolism. Baillieres Clin Endocrinol Metab 10(4):551–570
Fui MN, Dupuis P, Grossmann M (2014) Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl 16(2):223–231. https://doi.org/10.4103/1008-682X.122365
Rabijewski M, Papierska L, Piatkiewicz P (2016) The relationships between anabolic hormones and body composition in middle-aged and elderly men with prediabetes: a cross-sectional study. J Diabetes Res 2016:1747261. https://doi.org/10.1155/2016/1747261
Swiecicka A, Lunt M, Ahern T, O’Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, MEJ L, Pendleton N, Punab M, Slowikowska-Hilczer J, Vanderschueren D, Huhtaniemi IT, FCW W, Rutter MK, Group ES (2017) Nonandrogenic anabolic hormones predict risk of frailty: European male ageing study prospective data. J Clin Endocrinol Metab 102(8):2798–2806. https://doi.org/10.1210/jc.2017-00090
Valenzuela RE, Ponce JA, Morales-Figueroa GG, Muro KA, Carreon VR, Aleman-Mateo H (2013) Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging 8:1143–1148. https://doi.org/10.2147/CIA.S49810
Roubenoff R (2003) Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 6(3):295–299. https://doi.org/10.1097/01.mco.0000068965.34812.62
Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M, Health ABCS (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64(11):1183–1189. https://doi.org/10.1093/gerona/glp097
Murton AJ (2015) Muscle protein turnover in the elderly and its potential contribution to the development of sarcopenia. Proc Nutr Soc 74(4):387–396. https://doi.org/10.1017/S0029665115000130
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18(5):388–395. https://doi.org/10.1016/j.numecd.2007.10.002
Kohara K (2014) Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 45(1):15–25. https://doi.org/10.1007/s12020-013-9992-0
Wannamethee SG, Atkins JL (2015) Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc 74(4):405–412. https://doi.org/10.1017/S002966511500169X
Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33(7):1652–1654. https://doi.org/10.2337/dc10-0107
Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ (2013) Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 56(1):270–278. https://doi.org/10.1016/j.archger.2012.09.007
Kim TN, Park MS, Kim YJ, Lee EJ, Kim MK, Kim JM, Ko KS, Rhee BD, Won JC (2014) Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS One 9(6):e100118. https://doi.org/10.1371/journal.pone.0100118
Lu CW, Yang KC, Chang HH, Lee LT, Chen CY, Huang KC (2013) Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract 7(4):e301–e307. https://doi.org/10.1016/j.orcp.2012.02.003
Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 5(5):e10805. https://doi.org/10.1371/journal.pone.0010805
Stephen WC, Janssen I (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 13(5):460–466
Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2007) Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 86(5):1339–1346
Tian S, Xu Y (2016) Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int 16(2):155–166. https://doi.org/10.1111/ggi.12579
Baumgartner RN (2000) Body composition in healthy aging. Ann N Y Acad Sci 904:437–448
Davison KK, Ford ES, Cogswell ME, Dietz WH (2002) Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 50(11):1802–1809
Zoico E, Di Francesco V, Guralnik JM, Mazzali G, Bortolani A, Guariento S, Sergi G, Bosello O, Zamboni M (2004) Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 28(2):234–241. https://doi.org/10.1038/sj.ijo.0802552
Visser M, Kritchevsky SB, Goodpaster BH, Newman AB, Nevitt M, Stamm E, Harris TB (2002) Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc 50(5):897–904
Lafortuna CL, Maffiuletti NA, Agosti F, Sartorio A (2005) Gender variations of body composition, muscle strength and power output in morbid obesity. Int J Obes 29(7):833–841. https://doi.org/10.1038/sj.ijo.0802955
Friedmann JM, Elasy T, Jensen GL (2001) The relationship between body mass index and self-reported functional limitation among older adults: a gender difference. J Am Geriatr Soc 49(4):398–403
Angleman SB, Harris TB, Melzer D (2006) The role of waist circumference in predicting disability in periretirement age adults. Int J Obes 30(2):364–373. https://doi.org/10.1038/sj.ijo.0803130
Moreira MA, Zunzunegui MV, Vafaei A, da Camara SM, Oliveira TS, Maciel AC (2016) Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil. BMC Public Health 16:43. https://doi.org/10.1186/s12889-015-2667-4
Bouchonville MF, Villareal DT (2013) Sarcopenic obesity: how do we treat it? Curr Opin Endocrinol Diabetes Obes 20(5):412–419. https://doi.org/10.1097/01.med.0000433071.11466.7f
Molino S, Dossena M, Buonocore D, Verri M (2016) Sarcopenic obesity: an appraisal of the current status of knowledge and management in elderly people. J Nutr Health Aging 20(7):780–788. https://doi.org/10.1007/s12603-015-0631-8
Sgro P, Sansone M, Sansone A, Sabatini S, Borrione P, Romanelli F, Di Luigi L (2018) Physical exercise, nutrition and hormones: three pillars to fight sarcopenia. Aging male:1–14. https://doi.org/10.1080/13685538.2018.1439004
Waters DL, Ward AL, Villareal DT (2013) Weight loss in obese adults 65years and older: a review of the controversy. Exp Gerontol 48(10):1054–1061. https://doi.org/10.1016/j.exger.2013.02.005
Villareal DT, Banks M, Sinacore DR, Siener C, Klein S (2006) Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 166(8):860–866. https://doi.org/10.1001/archinte.166.8.860
Svetkey LP, Clark JM, Funk K, Corsino L, Batch BC, Hollis JF, Appel LJ, Brantley PJ, Loria CM, Champagne CM, Vollmer WM, Stevens VJ (2014) Greater weight loss with increasing age in the weight loss maintenance trial. Obesity 22(1):39–44. https://doi.org/10.1002/oby.20506
Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, Napoli N, Qualls C, Shah K (2011) Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 364(13):1218–1229. https://doi.org/10.1056/NEJMoa1008234
Murphy CH, Churchward-Venne TA, Mitchell CJ, Kolar NM, Kassis A, Karagounis LG, Burke LM, Hawley JA, Phillips SM (2015) Hypoenergetic diet-induced reductions in myofibrillar protein synthesis are restored with resistance training and balanced daily protein ingestion in older men. Am J Phys Endocrinol Metab 308(9):E734–E743. https://doi.org/10.1152/ajpendo.00550.2014
Muscariello E, Nasti G, Siervo M, Di Maro M, Lapi D, D'Addio G, Colantuoni A (2016) Dietary protein intake in sarcopenic obese older women. Clin Interv Aging 11:133–140. https://doi.org/10.2147/CIA.S96017
Pantelic S, Popovic M, Miloradovic V, Kostic R, Milanovic Z, Bratic M (2013) Effects of short-term exercise training on cardiorespiratory fitness of male adults with myocardial infarction. J Phys Ther Sci 25(8):929–935. https://doi.org/10.1589/jpts.25.929
Argiles JM, Orpi M, Busquets S, Lopez-Soriano FJ (2012) Myostatin: more than just a regulator of muscle mass. Drug Discov Today 17(13-14):702–709. https://doi.org/10.1016/j.drudis.2012.02.001
McMahon G, Morse CI, Burden A, Winwood K, Onambele GL (2014) Muscular adaptations and insulin-like growth factor-1 responses to resistance training are stretch-mediated. Muscle Nerve 49(1):108–119. https://doi.org/10.1002/mus.23884
Fujita S, Rasmussen BB, Cadenas JG, Drummond MJ, Glynn EL, Sattler FR, Volpi E (2007) Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 56(6):1615–1622. https://doi.org/10.2337/db06-1566
Timmerman KL, Dhanani S, Glynn EL, Fry CS, Drummond MJ, Jennings K, Rasmussen BB, Volpi E (2012) A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr 95(6):1403–1412. https://doi.org/10.3945/ajcn.111.020800
Lanza IR, Nair KS (2009) Muscle mitochondrial changes with aging and exercise. Am J Clin Nutr 89(1):467S–471S. https://doi.org/10.3945/ajcn.2008.26717D
Thornell LE (2011) Sarcopenic obesity: satellite cells in the aging muscle. Curr Opin Clin Nutr Metab Care 14(1):22–27. https://doi.org/10.1097/MCO.0b013e3283412260
Lambert CP, Wright NR, Finck BN, Villareal DT (2008) Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol 105(2):473–478. https://doi.org/10.1152/japplphysiol.00006.2008
Frimel TN, Sinacore DR, Villareal DT (2008) Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci Sports Exerc 40(7):1213–1219. https://doi.org/10.1249/MSS.0b013e31816a85ce
Liao CD, Tsauo JY, Lin LF, Huang SW, Ku JW, Chou LC, Liou TH (2017) Effects of elastic resistance exercise on body composition and physical capacity in older women with sarcopenic obesity: a CONSORT-compliant prospective randomized controlled trial. Medicine 96(23):e7115. https://doi.org/10.1097/MD.0000000000007115
Liao CD, Tsauo JY, Huang SW, Ku JW, Hsiao DJ, Liou TH (2018) Effects of elastic band exercise on lean mass and physical capacity in older women with sarcopenic obesity: a randomized controlled trial. Sci Rep 8(1):2317. https://doi.org/10.1038/s41598-018-20677-7
Marcos-Pardo PJ, Martinez-Rodriguez A, Gil-Arias A (2018) Impact of a motivational resistance-training programme on adherence and body composition in the elderly. Sci Rep 8(1):1370. https://doi.org/10.1038/s41598-018-19764-6
Dillon EL (2013) Nutritionally essential amino acids and metabolic signaling in aging. Amino Acids 45(3):431–441. https://doi.org/10.1007/s00726-012-1438-0
Nowson C, O’Connell S (2015) Protein requirements and recommendations for older people: a review. Nutrients 7(8):6874–6899. https://doi.org/10.3390/nu7085311
Baum JI, Kim IY, Wolfe RR (2016) Protein consumption and the elderly: what Is the optimal level of intake? Nutrients 8(6). https://doi.org/10.3390/nu8060359
Phillips SM (2017) Current Concepts and Unresolved Questions in Dietary Protein Requirements and Supplements in Adults. Front Nutr 4:13. https://doi.org/10.3389/fnut.2017.00013
Volpi E, Mittendorfer B, Wolf SE, Wolfe RR (1999) Oral amino acids stimulate muscle protein anabolism in the elderly despite higher first-pass splanchnic extraction. Am J Phys 277(3 Pt 1):E513–E520
Paddon-Jones D, Rasmussen BB (2009) Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 12(1):86–90. https://doi.org/10.1097/MCO.0b013e32831cef8b
Cuthbertson DJ, Babraj J, Smith K, Wilkes E, Fedele MJ, Esser K, Rennie M (2006) Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise. Am J Phys Endocrinol Metab 290(4):E731–E738. https://doi.org/10.1152/ajpendo.00415.2005
Symons TB, Schutzler SE, Cocke TL, Chinkes DL, Wolfe RR, Paddon-Jones D (2007) Aging does not impair the anabolic response to a protein-rich meal. Am J Clin Nutr 86(2):451–456
Verreijen AM, Verlaan S, Engberink MF, Swinkels S, de Vogel-van den Bosch J, Weijs PJ (2015) A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: a double-blind randomized controlled trial. Am J Clin Nutr 101(2):279–286. https://doi.org/10.3945/ajcn.114.090290
Komar B, Schwingshackl L, Hoffmann G (2015) Effects of leucine-rich protein supplements on anthropometric parameter and muscle strength in the elderly: a systematic review and meta-analysis. J Nutr Health Aging 19(4):437–446. https://doi.org/10.1007/s12603-014-0559-4
Ispoglou T, White H, Preston T, McElhone S, McKenna J, Hind K (2016) Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years. Eur J Clin Nutr 70(2):182–188. https://doi.org/10.1038/ejcn.2015.91
Sammarco R, Marra M, Di Guglielmo ML, Naccarato M, Contaldo F, Poggiogalle E, Donini LM, Pasanisi F (2017) Evaluation of hypocaloric diet with protein supplementation in middle-aged sarcopenic obese women: a pilot study. Obes Facts 10(3):160–167. https://doi.org/10.1159/000468153
Augustin H, McGourty K, Steinert JR, Cocheme HM, Adcott J, Cabecinha M, Vincent A, Halff EF, Kittler JT, Boucrot E, Partridge L (2017) Myostatin-like proteins regulate synaptic function and neuronal morphology. Development 144(13):2445–2455. https://doi.org/10.1242/dev.152975
Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF (2002) Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J Nutr Health Aging 6(5):343–348
Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, Georges M (1997) A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17(1):71–74. https://doi.org/10.1038/ng0997-71
Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350(26):2682–2688. https://doi.org/10.1056/NEJMoa040933
Shan T, Liang X, Bi P, Kuang S (2013) Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 27(5):1981–1989. https://doi.org/10.1096/fj.12-225755
Wilkes JJ, Lloyd DJ, Gekakis N (2009) Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58(5):1133–1143. https://doi.org/10.2337/db08-0245
Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007) Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 104(6):1835–1840. https://doi.org/10.1073/pnas.0604893104
Jackson MF, Luong D, Vang DD, Garikipati DK, Stanton JB, Nelson OL, Rodgers BD (2012) The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism. J Endocrinol 213(3):263–275. https://doi.org/10.1530/JOE-11-0455
Krivickas LS, Walsh R, Amato AA (2009) Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve 39(1):3–9. https://doi.org/10.1002/mus.21200
Gonzalez-Freire M, Rodriguez-Romo G, Santiago C, Bustamante-Ara N, Yvert T, Gomez-Gallego F, Serra Rexach JA, Ruiz JR, Lucia A (2010) The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan. Age 32(3):405–409. https://doi.org/10.1007/s11357-010-9139-7
Garatachea N, Pinos T, Camara Y, Rodriguez-Romo G, Emanuele E, Ricevuti G, Venturini L, Santos-Lozano A, Santiago-Dorrego C, Fiuza-Luces C, Yvert T, Andreu AL, Lucia A (2013) Association of the K153R polymorphism in the myostatin gene and extreme longevity. Age 35(6):2445–2454. https://doi.org/10.1007/s11357-013-9513-3
Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM, Hurley BF (1999) Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 62(2):203–207. https://doi.org/10.1006/geno.1999.5984
Gruson D, Ginion A, Lause P, Ketelslegers JM, Thissen JP, Bertrand L (2012) Urotensin II and urocortin trigger the expression of myostatin, a negative regulator of cardiac growth, in cardiomyocytes. Peptides 33(2):351–353. https://doi.org/10.1016/j.peptides.2011.12.017
Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS (2013) Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab 98(5):1891–1900. https://doi.org/10.1210/jc.2012-3695, 10.1210/jc.2013-2227
Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90(2):678–688. https://doi.org/10.1210/jc.2004-1184
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task Force ES (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(6):2536–2559. https://doi.org/10.1210/jc.2009-2354
Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P (2012) Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev 33(3):314–377. https://doi.org/10.1210/er.2012-1002
Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323(1):1–6. https://doi.org/10.1056/NEJM199007053230101
Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288(18):2282–2292
Liu YL, Lu CW, Shi L, Liou YM, Lee LT, Huang KC (2015) Low intensive lifestyle modification in young adults with metabolic syndrome a community-based interventional study in Taiwan. Medicine 94(22):e916. https://doi.org/10.1097/MD.0000000000000916
White HK, Petrie CD, Landschulz W, MacLean D, Taylor A, Lyles K, Wei JY, Hoffman AR, Salvatori R, Ettinger MP, Morey MC, Blackman MR, Merriam GR, Capromorelin Study G (2009) Effects of an oral growth hormone secretagogue in older adults. J Clin Endocrinol Metab 94(4):1198–1206. https://doi.org/10.1210/jc.2008-0632
Makimura H, Feldpausch MN, Rope AM, Hemphill LC, Torriani M, Lee H, Grinspoon SK (2012) Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J Clin Endocrinol Metab 97(12):4769–4779. https://doi.org/10.1210/jc.2012-2794
Villareal DT, Holloszy JO (2006) DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Phys Endocrinol Metab 291(5):E1003–E1008. https://doi.org/10.1152/ajpendo.00100.2006
Corona G, Rastrelli G, Giagulli VA, Sila A, Sforza A, Forti G, Mannucci E, Maggi M (2013) Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J Clin Endocrinol Metab 98(9):3615–3626. https://doi.org/10.1210/jc.2013-1358
Schroeder ET, Zheng L, Yarasheski KE, Qian D, Stewart Y, Flores C, Martinez C, Terk M, Sattler FR (2004) Treatment with oxandrolone and the durability of effects in older men. J Appl Physiol 96(3):1055–1062. https://doi.org/10.1152/japplphysiol.00808.2003
Morley JE, von Haehling S, Anker SD (2014) Are we closer to having drugs to treat muscle wasting disease? J Cachexia Sarcopenia Muscle 5(2):83–87. https://doi.org/10.1007/s13539-014-0149-7
Mueller TC, Bachmann J, Prokopchuk O, Friess H, Martignoni ME (2016) Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans? BMC Cancer 16:75. https://doi.org/10.1186/s12885-016-2121-8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Cretoiu, S.M., Zugravu, C.A. (2018). Nutritional Considerations in Preventing Muscle Atrophy. In: Xiao, J. (eds) Muscle Atrophy. Advances in Experimental Medicine and Biology, vol 1088. Springer, Singapore. https://doi.org/10.1007/978-981-13-1435-3_23
Download citation
DOI: https://doi.org/10.1007/978-981-13-1435-3_23
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1434-6
Online ISBN: 978-981-13-1435-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)